SOMERSET, N.J., July 11 /PRNewswire-FirstCall/ -- inVentiv Health, Inc. today announced that it will release its Second Quarter results and conduct a conference call on Wednesday, August 8, 2007 at 9:00 a.m. Eastern Time.
Conference Call Details
To listen, please dial 800-358-8448 (Domestic) or 706-634-1367 (International) Live and Archived Webcast: http://www.inventivhealth.com/. A replay of the call will be available immediately following the call through August 15, 2007 at 800-642-1687. The conference ID number for the replay is 7200339.
The conference call also will be webcast live on the Internet at http://www.inventivhealth.com/. To listen, please go to the site at least 15 minutes in advance of the call to register, download and install any necessary audio software.
About inVentiv Health
inVentiv Health is the leading provider of commercialization and complementary services to the healthcare industry globally. inVentiv delivers its customized clinical, sales, marketing and communications solutions through its three core business segments: inVentiv Clinical, inVentiv Communications and inVentiv Commercial. inVentiv Health's client roster is comprised of more than 200 leading pharmaceutical, biotech, life sciences and healthcare payor companies, including the top 20 global pharmaceutical manufacturers. For more information, visit http://www.inventivhealth.com/.
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements involve known and unknown risks that may cause inVentiv Health's performance to differ materially. Such risks include, without limitation: changes in trends in the pharmaceutical industry or in pharmaceutical outsourcing; our ability to compete successfully with other services in the market; our ability to maintain large client contracts or to enter into new contracts; uncertainties related to future incentive payments; and, our ability to operate successfully in new lines of business. Readers of this press release are referred to documents filed from time to time by inVentiv Health Inc. with the Securities and Exchange Commission for further discussion of these and other factors.
